You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 23, 2024

LUVOX CR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Luvox Cr patents expire, and when can generic versions of Luvox Cr launch?

Luvox Cr is a drug marketed by Jazz Pharms and is included in one NDA.

The generic ingredient in LUVOX CR is fluvoxamine maleate. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the fluvoxamine maleate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Luvox Cr

A generic version of LUVOX CR was approved as fluvoxamine maleate by UPSHER SMITH LABS on November 29th, 2000.

  Sign Up

AI Research Assistant
Sample questions
  • What is the 5 year forecast for LUVOX CR?
  • What are the global sales for LUVOX CR?
  • What is Average Wholesale Price for LUVOX CR?
Drug patent expirations by year for LUVOX CR
Anatomical Therapeutic Chemical (ATC) Classes for LUVOX CR
Paragraph IV (Patent) Challenges for LUVOX CR
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
LUVOX CR Extended-release Capsules fluvoxamine maleate 100 mg 022033 1 2009-04-20
LUVOX CR Extended-release Capsules fluvoxamine maleate 150 mg 022033 1 2009-04-13

US Patents and Regulatory Information for LUVOX CR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jazz Pharms LUVOX CR fluvoxamine maleate CAPSULE, EXTENDED RELEASE;ORAL 022033-001 Feb 28, 2008 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Jazz Pharms LUVOX CR fluvoxamine maleate CAPSULE, EXTENDED RELEASE;ORAL 022033-002 Feb 28, 2008 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LUVOX CR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Jazz Pharms LUVOX CR fluvoxamine maleate CAPSULE, EXTENDED RELEASE;ORAL 022033-001 Feb 28, 2008 ⤷  Sign Up ⤷  Sign Up
Jazz Pharms LUVOX CR fluvoxamine maleate CAPSULE, EXTENDED RELEASE;ORAL 022033-002 Feb 28, 2008 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for LUVOX CR

See the table below for patents covering LUVOX CR around the world.

Country Patent Number Title Estimated Expiration
Cyprus 1107750 ⤷  Sign Up
South Africa 200110401 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations. ⤷  Sign Up
European Patent Office 1852111 ⤷  Sign Up
Algeria 3256 PREPARATIONS D'INHIBITEURS SPECIFIQUES DU RECAPTAGE DE LA SEROTONINE A LIBERATION MULTIPARTICULAIRE REGULEE ⤷  Sign Up
Japan 2003500348 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.